asct in relapsed myeloma patients
Published 3 years ago • 186 plays • Length 2:40Download video MP4
Download video MP3
Similar videos
-
3:01
treatment approaches for asct-eligible myeloma patients in the frontline
-
4:06
addressing the challenge of post-asct relapse in multiple myeloma & the value of precision medicine
-
1:41
results from determination: rvd with or without asct
-
3:34
maintenance therapy following salvage asct for multiple myeloma
-
6:23
how long will i live with multiple myeloma and is there a cure?
-
5:30
why is myeloma hard to treat? what is meant by a signaling pathway?
-
4:04
the future of myeloma treatment and the possibility of cure
-
1:09
using mrd and pet/ct to assess responses post-asct in myeloma
-
1:01
car-t: myeloma toxicities
-
1:04
the changing role of autosct in the treatment of multiple myeloma in the era of novel agents
-
5:49
magnetismm-3 extended follow up results: elranatamab monotherapy in r/r multiple myeloma
-
1:59
the growing importance of celmods in the treatment of r/r multiple myeloma
-
2:30
a new era of treatment for multiple myeloma
-
0:50
the expanding therapeutic landscape of r/r multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
3:04
monumental-1 update: talquetamab in r/r multiple myeloma
-
3:27
car-t cells in myeloma
-
2:39
a look into the future of multiple myeloma treatment: t-cell redirecting therapies vs autohsct
-
2:29
phase i first-in-human study of alnuctamab in patients with r/r multiple myeloma
-
2:58
bcma 2 1 t-cell engager cc-93269 in patients with r/r myeloma
-
3:13
how to optimally sequence agents in the expanding treatment armamentarium of multiple myeloma